Sign In
Buy ILMN
$170.93
+8.38 (+5.16%)
At Close: Jun 03, 2026
Illumina, Inc. (ILMN) CEO Francis deSouza on Q1 2022 Results - Earnings Call Transcript
09:22pm, Thursday, 05'th May 2022
Illumina, Inc. (NASDAQ:ILMN ) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Salli Schwartz - Vice President, Investor Relations Francis deSouza - President & Chief Execu
IYH: Diversified Healthcare ETF Suitable For Short Term Investment
04:24am, Tuesday, 03'rd May 2022 Seeking Alpha
The IYH ETF has posted strong price returns over the medium and long term, but generated 1% yield. Read why I'll prefer to make IYH a trading instrument.
23andMe CEO Anne Wojcicki on Bringing Health Information Directly to People
07:35pm, Friday, 29'th Apr 2022 The Motley Fool
A better understanding of genes could dramatically improve healthcare.
2 Reasons to Buy Illumina, and 1 Reason to Sell
12:50pm, Thursday, 28'th Apr 2022 The Motley Fool
Shares are near a 52-week low, but is that cheap enough?
This Chart Is Why I'm Not Worried About Guardant Health
10:20am, Thursday, 28'th Apr 2022 The Motley Fool
The leading innovator in the liquid biopsy space has huge addressable markets ahead of it.
2 Reasons to Buy Thermo Fisher Scientific, and 1 Reason to Sell
09:55am, Thursday, 28'th Apr 2022 The Motley Fool
The life sciences giant could end up being a victim of its own success.
Markets Pare Early Losses As Musk-Twitter Agree On Buyout Deal
08:04pm, Monday, 25'th Apr 2022 Benzinga
U.S. indices pared early losses and closed higher Monday.
Markets were trading lower to start the session as stocks continued to fall after the Fed last week indicated it may move more quickly on rate
QGEN or ILMN: Which Is the Better Value Stock Right Now?
03:40pm, Monday, 25'th Apr 2022 Zacks Investment Research
QGEN vs. ILMN: Which Stock Is the Better Value Option?
QGEN or ILMN: Which Is the Better Value Stock Right Now?
12:47pm, Monday, 25'th Apr 2022
QGEN vs. ILMN: Which Stock Is the Better Value Option?
Here's Why You Should Hold on to Illumina (ILMN) Stock For Now
02:13pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Investors are optimistic about Illumina's (ILMN) strategic collaborations and strong international sales.
Lessons For Elon Musk: 5 Notorious Failed Hostile Takeovers
01:59pm, Friday, 15'th Apr 2022 Benzinga
As any student of industry knows, Elon Musk is hardly the first person to attempt a hostile takeover. But while the Tesla (NASDAQ: TSLA) chieftain’s $54.20 per share bid for Twitter (NYSE: TWTR) con
Illumina to Announce First Quarter 2022 Financial Results on Thursday, May 5, 2022
04:05pm, Thursday, 14'th Apr 2022
SAN DIEGO , April 14, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that it will issue results for the first quarter 2022 following the close of market on Thursday, May 5, 2022.
Illumina (ILMN) Hurt by Rising Costs, Tough Competition
12:44pm, Thursday, 14'th Apr 2022 Zacks Investment Research
Regulatory complications are raising the legal expenses for Illumina (ILMN), thereby building pressure on the bottom line.
Illumina (ILMN) Hurt by Rising Costs, Tough Competition
09:47am, Thursday, 14'th Apr 2022
Regulatory complications are raising the legal expenses for Illumina (ILMN), thereby building pressure on the bottom line.
Illumina (ILMN) Launches Genomic Solution Hub in Brazil
02:10pm, Wednesday, 13'th Apr 2022 Zacks Investment Research
Illumina's (ILMN) customers and partners in Brazil currently span basic research, applied markets to clinical labs and healthcare institutions.
